{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:14Z","timestamp":1790283314424,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijantimicag.2020.106200","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T21:16:57Z","timestamp":1602883017000},"page":"106200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Bacteriophage\u2013antibiotic combinations against ciprofloxacin\/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model"],"prefix":"10.1016","volume":"56","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamta","family":"Tkhilaishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bernal Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Trampuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-6544","authenticated-orcid":false,"given":"Mercedes","family":"Gonzalez Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106200_bib0001","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3389\/fmicb.2019.02935","article-title":"A new antibiotic-loaded sol-gel can prevent bacterial prosthetic joint infection: from in vitro studies to an in vivo model","volume":"10","author":"Aguilera-Correa","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1302\/2058-5241.4.180092","article-title":"Periprosthetic joint infection: current concepts and outlook","volume":"4","author":"Izakovicova","year":"2019","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121737","article-title":"Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets","volume":"3","author":"Thompson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7150\/jbji.24285","article-title":"Treatment of prosthetic joint infection with debridement, antibiotics and irrigation with implant retention\u2014a narrative review","volume":"3","author":"Sousa","year":"2018","journal-title":"J Bone Jt Infect"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/jcm8020220","article-title":"Orthopedic implant-associated infection by multidrug resistant Enterobacteriaceae","volume":"8","author":"Pfang","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0006","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2018.10.018","article-title":"Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: role of surgery and impact of colistin administration","volume":"53","author":"Papadopoulos","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0007","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3389\/fmicb.2019.02522","article-title":"Synergistic activity of fosfomycin, ciprofloxacin, and gentamicin against Escherichia coli and Pseudomonas aeruginosa biofilms","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antibiotics3030270","article-title":"Bacteriophages and biofilms","volume":"3","author":"Harper","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fmicb.2018.00127","article-title":"Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms","volume":"9","author":"Kumaran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02231-19","article-title":"Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalized in osteoblasts","volume":"64","author":"Kolenda","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary rationale for phages as complements of antibiotics","volume":"24","author":"Torres-Barcelo","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0013","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","article-title":"Phage\u2013antibiotic synergy (PAS): \u03b2-lactam and quinolone antibiotics stimulate virulent phage growth","volume":"2","author":"Comeau","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","article-title":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","volume":"52","author":"Tkhilaishvili","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0015","doi-asserted-by":"crossref","first-page":"26717","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0017","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex phage\u2013antibiotic synergy (PAS): antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0018","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00705-018-3811-0","article-title":"Piperacillin and ceftazidime produce the strongest synergistic phage\u2013antibiotic effect in Pseudomonas aeruginosa","volume":"163","author":"Uchiyama","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0019","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.09.024","article-title":"Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa","volume":"551","author":"Lin","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0020","doi-asserted-by":"crossref","first-page":"14140","DOI":"10.1038\/s41598-018-32344-y","article-title":"Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii","volume":"8","author":"Jansen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/antibiotics8030103","article-title":"Synergistic action of phage and antibiotics: parameters to enhance the killing efficacy against mono and dual-species biofilms","volume":"8","author":"Akturk","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0022","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/microorganisms6040125","article-title":"Sequential combined effect of phages and antibiotics on the inactivation of Escherichia coli","volume":"6","author":"Lopes","year":"2018","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2017.07.015","article-title":"Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli","volume":"240","author":"Valerio","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage\u2013antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0025","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/v6103778","article-title":"Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms","volume":"6","author":"Coulter","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0026","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/AAC.02764-13","article-title":"A novel approach utilizing biofilm time\u2013kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus","volume":"58","author":"Barber","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0027","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jmii.2018.12.007","article-title":"Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model","volume":"53","author":"Li","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00401-18","article-title":"Complete genome sequences of two Escherichia phages isolated from wastewater in Finland","volume":"6","author":"Kiljunen","year":"2018","journal-title":"Genome Announc"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0029","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement","year":"2015"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fmicb.2019.00574","article-title":"Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species","volume":"10","author":"Manohar","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0031","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3389\/fmicb.2019.01984","article-title":"Bacteriophages reduce pathogenic Escherichia coli counts in mice without distorting gut microbiota","volume":"10","author":"Dissanayake","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0032","first-page":"363","article-title":"Phage therapy targeting Escherichia coli\u2014a story with no end?","author":"Bolocan","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0033","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fmicb.2014.00051","article-title":"The factors affecting effectiveness of treatment in phages therapy","volume":"5","author":"Ly-Chatain","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0034","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1139\/w01-059","article-title":"Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm","volume":"47","author":"Corbin","year":"2001","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0036","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/antibiotics8040182","article-title":"Phage\u2013antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?","volume":"8","author":"Abedon","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0037","article-title":"Phage\u2013antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Liu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0038","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/cix184","article-title":"The lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by \u03b2-lactams","volume":"64","author":"Dufour","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0039","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00253-018-8811-1","article-title":"Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?","volume":"102","author":"Maciejewska","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0040","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1248\/bpb.25.1658","article-title":"Time- and dose-dependent effect of fosfomycin on suppression of infection-induced endotoxin shock in mice","volume":"25","author":"Kawaguchi","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2020.106200_bib0041","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkl464","article-title":"Immunomodulatory effects of fosfomycin in an endotoxin model in human blood","volume":"59","author":"Zeitlinger","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:42:00Z","timestamp":1760377320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920304064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0924857920304064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106200","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteriophage\u2013antibiotic combinations against ciprofloxacin\/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106200"}}